BSE filing, NSE: KDGREEN. Summary written from the filing by ALFA Finder's alert engine.
Manbro Industries Ltd: key numbers
- Share price
- ₹48.84
- Market cap
- ₹495.8 Cr
- Revenue (annual)
- ₹63.34 Cr
- Net profit (annual)
- ₹2.99 Cr
- P/E (TTM)
- 98.1×Sector 49.0×
- Promoter holding
- 56.64%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manbro Industries Ltd
All →KD Green Industries Other Announcement
KD Green Industries Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
KD Green Industries Annual General Meeting
KD Green Industries held its 34th Annual General Meeting on September 30, 2026. Shareholders adopted financial statements and approved various related party transactions.
KD Green Industries Annual Report
KD Green Industries Ltd has filed its Annual Report for the financial year 2025-26, providing details on corporate governance, financial statements, and company performance.
KD Green Industries Annual General Meeting
KD Green Industries has issued a notice for its 34th Annual General Meeting scheduled for September 30, 2026. The meeting will seek shareholder approval for various resolutions.
KD Green Industries Board Meeting Outcome
KD Green Industries approved related party transactions and convened its Annual General Meeting for September 30, 2026. Shareholders will vote on these proposals at the upcoming AGM.
KD Green Industries Bags ₹7.79 Cr Order from Star Infratech
KD Green Industries' subsidiary, Shivam Pipe Industries, secured a ₹ 7.79 Crore order from Star Infratech for supplying GI Steel Tubular Poles.
- Value
- ₹7.79 Cr
- From
- Star Infratech
Other regulatory approval announcements
All →Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.
Kalyani Cast-Tech Regulatory Approval
Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.
Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Canara Bank Regulatory Approval
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
- Value
- ₹1,500 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.